FDA Approved: OZEMPIC — Original Application (Novo Nordisk)

View source ↗

Summary

The FDA approves Ozempic (semaglutide) under NDA209637 for adults with Type 2 diabetes mellitus to improve glycemic control (original application).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• OZEMPIC (semaglutide)

Snippet

ORIG AP for OZEMPIC (SEMAGLUTIDE)